| Literature DB >> 33437097 |
H Mater Mahnashi1, Ashraf M Mahmoud1,2, A Saad Alkahtani3, Mohamed M El-Wekil2.
Abstract
In this research paper, an innovative electrochemical sensor was suggested for simultaneous voltammetric analysis of azithromycin (AZM) and hydroxychloroquine (HCQ) for the first time. The sensor based on hydrothermal synthesis of vanadium disulfide quantum dots (VS2 QDs) and insertion within 3D N, S graphene aerogel (3D N, S @ GNA) and carbon nanotubes nanaostructure as a new and widely group of carbon nanomaterials. The nanocomposites were characterized morphologically using different techniques. In addition, the nanomaterials were characterized electrochemically using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and differential pulse voltammetry (DPV). The proposed electrochemical sensor showed wide dynamic linear ranges of 0.28-30 × 10-8 M and 0.84-22.5 × 10-8 M for analysis of AZM and HCQ, respectively. The limits of detection (LODs) based on signal to noise (S/N) 3:1 were found to be 0.091 × 10-8 M and 0.277 × 10-8 M for AZM and HCQ, respectively. Briefly, the electrochemical sensor had good stability, selectivity, reproducibility and feasibility for simultaneous detection of AZM and HCQ in presence of different interfering species.Entities:
Keywords: Azithromycin; Carboxylated carbon nanotubes; Graphene aerogel; Hydroxychloroquine; Modified sensor; VS2 QDs
Year: 2021 PMID: 33437097 PMCID: PMC7792520 DOI: 10.1016/j.microc.2021.105925
Source DB: PubMed Journal: Microchem J ISSN: 0026-265X Impact factor: 4.821
Scheme 1Main steps for preparation of VS2 QDs/cCNTs/N, S@GNA/GCE and its role for electro-oxidation of AZM and HCQ.
Fig 1(a) TEM, (b) FTIR, (c) Absorbance/fluorescence spectra and (d) size distribution of VS2 QDs.
Fig 2(A) CV scans of 15.0 µM of AZM and HCQ at VS2 QDs/3D N, S@ GNA/cCNTs/GCE in B.R. buffer (pH 6.0) at scan rate of 200 mv s−1 after preconcentration time of 150 s.
Scheme 2The electrochemical oxidation of AZM and HCQ at VS2 QDs/3D N, S@ GNA/cCNTs/GCE in B.R. buffer (pH 6.0).
Fig 3(A) The DPV responses of VS2 QDs/3D N, S@ GNA/cCNTs/GCE for simultaneous detection of AZM and HCQ in B.R. solution (pH 6.0) at different concentrations. (B) Calibration plots of Ipa vs. concentration under the optimum conditions of measurement.
Analysis of AZM and HCQ by VS2 QDs/3D N, S@ GNA/cCNTs/GCE in serum, urine and pharmaceutical formulations (n = 3).
| Samples | Added (×10−8 M) | Proposed sensor | HPLC method | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZM | HCQ | AZM | HCQ | ||||||||||
| Found (×10−8 M) | Recovery %±SD | RSD % | Found (×10−8 M) | Recovery %±SD | RSD % | Found (×10−8 M) | Recovery %±SD | RSD % | Found (×10−8 M) | Recovery %±SD | RSD % | ||
| Serum 1 | |||||||||||||
| 5.0 | 4.98 | 99.6 ± 2.5 | 2.5 | 5.05 | 101.0 ± 2.5 | 2.4 | 4.87 | 97.4 ± 3.2 | 3.3 | 5.13 | 102.6 ± 2.9 | 2.8 | |
| 15 | 15.34 | 102.3 ± 3.1 | 3.1 | 14.76 | 98.4 ± 3.3 | 3.3 | 15.34 | 102.3 ± 4.2 | 4.1 | 15.32 | 102.1 ± 3.5 | 3.4 | |
| Serum 2 | |||||||||||||
| 5.0 | 5.08 | 101.6 ± 2.9 | 2.9 | 4.97 | 99.4 ± 1.9 | 1.9 | 4.87 | 97.4 ± 2.6 | 2.7 | 4.92 | 98.4 ± 4.1 | 4.2 | |
| 15.0 | 14.78 | 98.5 ± 3.7 | 3.7 | 15.12 | 100.8 ± 2.1 | 2.1 | 14.56 | 97.1 ± 3.8 | 3.9 | 14.76 | 98.4 ± 3.8 | 3.8 | |
| Urine 1 | |||||||||||||
| 10.0 | 9.87 | 98.7 ± 2.9 | 3.0 | 10.25 | 102.5 ± 2.1 | 2.1 | 10.25 | 102.5 ± 2.5 | 2.5 | 9.56 | 95.6 ± 2.3 | 2.5 | |
| 20.0 | 19.45 | 97.3 ± 3.2 | 3.3 | 20.34 | 101.7 ± 3.0 | 3.0 | 20.67 | 103.4 ± 3.1 | 3.0 | 19.23 | 96.2 ± 3.6 | 3.7 | |
| Urine 2 | |||||||||||||
| 10.0 | 10.23 | 102.3 ± 2.8 | 2.7 | 10.27 | 102.7 ± 3.0 | 3.0 | 9.57 | 95.7 ± 3.8 | 4.0 | 10.47 | 104.7 ± 3.1 | 2.9 | |
| 20.0 | 20.89 | 104.5 ± 1.9 | 1.8 | 19.65 | 98.3 ± 2.1 | 2.2 | 19.45 | 97.3 ± 4.0 | 4.1 | 20.35 | 101.8 ± 2.5 | 2.4 | |
| Zithromax® capsules | |||||||||||||
| 10.0 | 9.78 | 97.8 ± 2.7 | 2.8 | – | – | – | 9.57 | 95.7 ± 2.8 | 2.9 | – | – | – | |
| 20.0 | 19.34 | 96.7 ± 3.1 | 3.2 | – | – | – | 19.45 | 97.3 ± 3.5 | 3.6 | – | – | – | |
| Hydroquine® tablets | |||||||||||||
| 10.0 | – | – | – | 9.67 | 96.7 ± 3.1 | 3.2 | – | –- | – | 10.12 | 101.2 ± 2.4 | 2.4 | |
| 20.0 | – | – | – | 20.67 | 103.4 ± 2.8 | 2.7 | – | –- | – | 19.78 | 98.5 ± 3.6 | 3.7 | |
Fig 4DPV scans of VS2 QDs/3D N, S@ GNA/cCNTs/GCE in measuring of 10.0 µM of AZM and HCQ in presence of different interfering species.